MDT Q3 2021 Earnings — Medtronic plc Revenue & Financial Results | Market Cap Arena

MDTMedtronic plc

$114B

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7.8B+0.8% YoY

Gross Profit

$5.2B66.3% margin

Operating Income

$1.3B16.4% margin

Net Income

$1.3B16.3% margin

EPS (Diluted)

$0.94

QoQ Revenue Growth

+1.7%

Cash Flow

Operating Cash Flow

$2.4B

Free Cash Flow

$2.0B

Stock-Based Comp.

$65M

Balance Sheet

Total Assets

$97.3B

Total Liabilities

$46.3B

Stockholders' Equity

$50.8B

Cash & Equivalents

$5.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7.8B	$7.7B	+0.8%
Gross Profit	$5.2B	$5.3B	-3.1%
Operating Income	$1.3B	$1.6B	-22.1%
Net Income	$1.3B	$1.9B	-33.7%

Revenue Segments

Cardiac and Vascular Group

$2.7B35%

Minimally Invasive Therapies Group

$2.3B30%

Restorative Therapies Group

$2.1B27%

Diabetes Group

$630M8%

Geographic Segments

UNITED STATES

$3.9B51%

Total Other Countries, Excluding United States and Ireland

$3.8B49%

IRELAND

$25M0%